Saba Capital Management disclosed a $43,617 acquisition of Gabelli Healthcare & WellnessRx Trust (NASDAQ: GRX) common stock in a regulatory filing dated August 27, 2026.
The hedge fund purchased 4,340 shares at $10.05 per share, according to the Form 4 filing with the U.S. Securities and Exchange Commission. The transaction, disclosed on August 28, 2026, brings Saba Capital’s indirect holdings in the trust to 2,155,133 shares, representing approximately 10% ownership.
Gabelli Healthcare & WellnessRx Trust is a closed-end fund focused on healthcare and wellness-related investments. The latest disclosure follows regulatory requirements for insider transactions and does not indicate a change in the fund’s investment strategy.
